The perinatal period should be considered in neonatal acute respiratory distress syndrome: comparison of the Montreux definition vs. the second pediatric acute lung injury consensus conference definition
- PMID: 37842021
- PMCID: PMC10568643
- DOI: 10.3389/fped.2023.1216073
The perinatal period should be considered in neonatal acute respiratory distress syndrome: comparison of the Montreux definition vs. the second pediatric acute lung injury consensus conference definition
Abstract
Background: The recently developed Montreux definition for neonatal acute respiratory distress syndrome (ARDS) partially differs from the Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) definition. Here, we compare the Montreux and PALICC-2 definitions regarding morbidity, mortality, and prognosis of neonatal cases of ARDS in order to evaluate which definition is more appropriate for newborns.
Methods: Neonates admitted to our neonatal intensive care unit between 1 January 2018 and 30 September 2019 who met the Montreux or PALICC-2 definition of neonatal ARDS were retrospectively analyzed (n = 472). One comparison was made between application of the Montreux and PALICC-2 definitions to neonates outside the perinatal period (> 7 d after birth). A second comparison was made between a diagnosis of neonatal ARDS within (≤ 7 d of birth) and outside (> 7 d after birth) the perinatal period using the Montreux definition.
Results: No significant differences in morbidity, mortality, severity, therapies, or prognosis were observed between neonates in the extra perinatal group according to the Montreux and PALICC-2 definitions. However, epidemiology, clinical course, and prognosis of neonatal ARDS within the perinatal period did differ from those outside the perinatal period according to the Montreux definition.
Conclusion: Neonates with ARDS within the perinatal period have unique triggers, epidemiology, clinical course, and prognosis, yet a similar pathobiology pattern, to neonates at other ages. Therefore, it may be essential to consider the perinatal period when defining neonatal ARDS.
Keywords: PALICC-2 definition; montreux definition; neonatal ARDS; newborns; perinatal period.
© 2023 Liu, Zhang, Wang, He, Ding, Chen and Shi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Comparison of the Montreux definition with the Berlin definition for neonatal acute respiratory distress syndrome.Eur J Pediatr. 2023 Apr;182(4):1673-1684. doi: 10.1007/s00431-023-04848-x. Epub 2023 Feb 3. Eur J Pediatr. 2023. PMID: 36735062
-
Comparison of Prevalence and Outcomes of Pediatric Acute Respiratory Distress Syndrome Using Pediatric Acute Lung Injury Consensus Conference Criteria and Berlin Definition.Front Pediatr. 2018 Apr 9;6:93. doi: 10.3389/fped.2018.00093. eCollection 2018. Front Pediatr. 2018. PMID: 29686979 Free PMC article.
-
Epidemiology of Neonatal Acute Respiratory Distress Syndrome: Prospective, Multicenter, International Cohort Study.Pediatr Crit Care Med. 2022 Jul 1;23(7):524-534. doi: 10.1097/PCC.0000000000002961. Epub 2022 May 9. Pediatr Crit Care Med. 2022. PMID: 35543390
-
Definition and global epidemiology of pediatric acute respiratory distress syndrome.Ann Transl Med. 2019 Oct;7(19):502. doi: 10.21037/atm.2019.09.31. Ann Transl Med. 2019. PMID: 31728355 Free PMC article. Review.
-
Characteristics, triggers, treatments, and experimental models of neonatal acute respiratory distress syndrome.Am J Physiol Lung Cell Mol Physiol. 2025 Apr 1;328(4):L512-L525. doi: 10.1152/ajplung.00312.2024. Epub 2025 Feb 9. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 39924963 Review.
Cited by
-
DNA Receptor Toll-Like Receptor 9 Signaling Pathway Plays a Major Immunomodulatory Role in Neonatal Acute Lung Injury by Inhibiting Inflammatory Response and Oxidative Stress.Cell Biochem Biophys. 2025 Sep;83(3):3225-3238. doi: 10.1007/s12013-025-01704-7. Epub 2025 Mar 7. Cell Biochem Biophys. 2025. PMID: 40053211 Clinical Trial.
References
LinkOut - more resources
Full Text Sources
Miscellaneous